These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2643581)

  • 21. Does Convit vaccine (BCG + Mycobacterium leprae) afford protection against biochemical changes in renal brush border membrane in experimental leprosy?
    Kohli M; Ganguly NK; Kaur S; Chugh KS; Sharma VK; Bhushnurmath SR
    Lepr Rev; 1991 Sep; 62(3):269-75. PubMed ID: 1795585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
    Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
    Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.
    Gelber RH; Brennan PJ; Hunter SW; Munn MW; Monson JM; Murray LP; Siu P; Tsang M; Engleman EG; Mohagheghpour N
    Infect Immun; 1990 Mar; 58(3):711-8. PubMed ID: 2407654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium bovis BCG but not Mycobacterium leprae induces TNF-alpha secretion in human monocytic THP-1 cells.
    Oliveira MM; Charlab R; Pessolani MC
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):973-8. PubMed ID: 11685264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccination against leprosy].
    Grosset J; Lecoeur H
    Acta Leprol; 1986; 4(3):289-91. PubMed ID: 3551467
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.
    Raman VS; O'Donnell J; Bailor HR; Goto W; Lahiri R; Gillis TP; Reed SG; Duthie MS
    Infect Immun; 2009 Dec; 77(12):5623-30. PubMed ID: 19786561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phase.
    Pönnighaus JM; Fine PE; Bliss L; Gruer PJ; Kapira-Mwamondwe B; Msosa E; Rees RJ; Clayton D; Pike MC; Sterne JA
    Lepr Rev; 1993 Dec; 64(4):338-56. PubMed ID: 8127221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection.
    Gelber RH; Murray L; Siu P; Tsang M
    Infect Immun; 1992 May; 60(5):1840-4. PubMed ID: 1563772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of three potential vaccines for leprosy in Bombay.
    Ganapati R; Revankar CR; Lockwood DN; Wilson RC; Price JE; Ashton P; Ashton LA; Holmes RM; Bennett C; Stanford JL
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):33-7. PubMed ID: 2659699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccines against leprosy.
    Lancet; 1987 May; 1(8543):1183-4. PubMed ID: 2883495
    [No Abstract]   [Full Text] [Related]  

  • 35. South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S10-3. PubMed ID: 11757173
    [No Abstract]   [Full Text] [Related]  

  • 36. Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
    Duthie MS; Coler RN; Laurance JD; Sampaio LH; Oliveira RM; Sousa AL; Stefani MM; Maeda Y; Matsuoka M; Makino M; Reed SG
    Infect Immun; 2014 Sep; 82(9):3979-85. PubMed ID: 25024362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice.
    Naito M; Matsuoka M; Ohara N; Nomaguchi H; Yamada T
    Vaccine; 1999 Dec; 18(9-10):795-8. PubMed ID: 10580191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of mice against M. leprae infection.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):222-6. PubMed ID: 776860
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the efficacy of candidate vaccines against M. leprae infection in mice.
    Sreevatsa ; Desikan KV
    Indian J Lepr; 1988 Apr; 60(2):252-9. PubMed ID: 3192974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.